[1] Novosyadlyy R,Vijayakumar A, Lann D,et al.Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-1R is required for oncogene activation and tumor initiation[J].Oncogene,2009,28(39):3477-3486. [2] Seccareccia E,Brodt P.The role of the insulin-like growth factor-1 receptor in malignancy: an update[J].Growth Horm IGF Res,2012,22(6):193-199. [3] Yerushalmi R,Gelmon KA ,Leung S,et al.Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes[J]. Breast Cancer Res Treat,2012,132: 131-142. [4] Ji RC.Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix[J].Lymph Res Biol,2006,4(2):83-100. [5] Chekhonin VP,Shein SA,Korchagina AA,et al.VEGF in tumor progression and targeted therapy[J]. Curr Cancer Drug Targets,2013,13(4):423-443. [6] Wang Z, Chen Y, Li X,et al.Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis[J]. Asian Pac J Cancer Prev,2012,13(1):27-31. [7] Kawakami M,Yanai Y,Hala F,et al.Vascular endothelial Growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model[J].Surg Today,2005,35(2):131-138. [8] 张梅娟,张丽华.免疫标记物D2-40在病理诊断中的应用和意义[J].诊断学理论与实践,2006,6(3):277-280. [9] Tang Y, Zhang D, Fallavollita L,et al.Vascular endothelial growth factor C expression and lymph node matastasis are regulated by the type Ⅰinsulin-like growth factor receptor[J].Cancer Res,2003,63(6):1161-1171. |